Anticorps Recombinant de lapin anti-TIMP1
TIMP1 Recombinant Antibody for IF/ICC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
IF/ICC
Conjugaison
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
230329E7
N° de cat : CL488-83151-5
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en IF/ICC | cellules HeLa, |
Dilution recommandée
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
CL488-83151-5 cible TIMP1 dans les applications de IF/ICC et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | Protéine recombinante |
Nom complet | TIMP metallopeptidase inhibitor 1 |
Masse moléculaire calculée | 23 kDa |
Numéro d’acquisition GenBank | BC000866 |
Symbole du gène | TIMP1 |
Identification du gène (NCBI) | 7076 |
Conjugaison | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 493 nm / 522 nm |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA |
Conditions de stockage | Stocker à -20 °C. Éviter toute exposition à la lumière. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
TIMP1 is a member of the family of matrix metalloproteinase inhibitors, which contains four members (TIMP1, TIMP2, TIMP3, and TIMP4). Tissue inhibitors of metalloproteinases (TIMPs) are multifaceted molecules that exhibit properties beyond their classical proteinase inhibitory function. TIMP1 has several MMP-independent functions such as modulation of angiogenesis, promotion of cell proliferation, and inhibition of apoptosis. TIMP1 plays important role in cell cycle regulation and cancer progression. Recently, clinical studies have shown that the aberrant expression of TIMP1 is associated with an unfavorable prognosis in a series of tumors, such as gastric cancer, papillary thyroid carcinoma, cutaneous melanoma and breast cancer. In pregnancy, TIMP1 plays a regulatory role in the process of implantation, particularly the cytotrophoblast invasion of the uterine endometrium. In pregnancy, TIMP1 plays a regulatory role in the process of implantation, particularly the cytotrophoblast invasion of the uterine endometrium.
Protocole
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 TIMP1 antibody CL488-83151-5 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |